Intervention not reported
Doxycycline (1 RCT, 80 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Placebo · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin IPC – not daily drainage, doxycycline, placebo Comparator…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Intervention Total studies: 9 Total participants: 883 · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
The intervention led to lower intervention Total studies: 9 Total participants: 883; GRADE not reported.
1 finding from 1 review
no estimate extracted
9 participants
GRADE not reported
Intervention not reported
Talc slurry (8 RCTs, 850 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Talc poudrage (2 RCTs, 380 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Bleomycin (1 RCT, 33 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Bleomycin (21 RCTs, 528 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
IPC –not daily drainage (3 RCTs, 343 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Doxycycline · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Placebo · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
IPC –not daily drainage (6 RCTs, 405 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Doxycycline (5 RCTs, 117 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Placebo (4 RCTs, 159 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Intervention not reported
Total studies: 30 * Total participants: 2004 No. interventions in network: 14 · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
The intervention led to lower total studies: 30 * Total participants: 2004 No. interventions in…; GRADE not reported.
1 finding from 1 review
no estimate extracted
30 participants
GRADE not reported
Intervention not reported
Talc slurry (9 RCTs; 823 participants) · adults with malignant pleural effusion Interventions: talc poudrage, bleomycin, IPC – not daily drainage, doxycycline, placebo Comparator…
1 finding from 1 review
Infliximab · people with chronic plaque psoriasis
Any systemic treatment probably leads to higher infliximab compared with placebo (moderate certainty).
2 findings from 1 review
Tildrakizumab · people with chronic plaque psoriasis
Any systemic treatment leads to higher tildrakizumab compared with placebo (high certainty).
2 findings from 1 review
Oral Tyrosine kinase 2 (TYK2) inhibitor · people with chronic plaque psoriasis
Any systemic treatment may leads to higher oral tyrosine kinase 2 (TYK2) inhibitor compared with placebo (low certainty).
2 findings from 1 review
Certolizumab · people with chronic plaque psoriasis
Any systemic treatment probably leads to higher certolizumab compared with placebo (moderate certainty).
2 findings from 1 review
Ciclosporin · people with chronic plaque psoriasis
It is very uncertain whether any systemic treatment changes ciclosporin compared with placebo (very low certainty).
2 findings from 1 review